Research detail

05.12 2012 11:46:12

go back

Veropharm reports weak results

by Anton Safonov

Veropharm has published operating and financial results for January-September, 2012, based on IFRS. The results are viewed as negative. Despite EBITDA margin expansion, revenue declined, as did net profit.

This research is available only to subscribers.
Please login to continue

To subscribe please contact us on sales@investcafe.co.uk or +7 495 792-06-19

Free Samples

Investcafe — pioneering independent research in Russia.

Investcafe longvertical